Press Releases - G1 Therapeutics, Inc.

Press Releases

Date	Title
7/22/20	G1 Therapeutics Announces License Agreement for Lerociclib
6/30/20	G1 Therapeutics and Boehringer Ingelheim Announce Co-Promotion Agreement for Trilaciclib in Small Cell Lung Cancer in the United States and Puerto Rico
6/22/20	G1 Therapeutics and Genor Biopharma Announce Exclusive License Agreement for Lerociclib in Asia-Pacific Region
6/1/20	G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital
5/13/20	G1 Therapeutics to Present Data Showing Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer at the ASCO20 Virtual Scientific Program
5/6/20	G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update
4/29/20	G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020
4/7/20	G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020
3/12/20	G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer
2/26/20	G1 Therapeutics Provides Fourth Quarter and Full-Year 2019 Corporate and Financial Update